Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVITA: Intravenous therapy for severe acute asthma in children and young people
ISRCTN26012511Phase 3Recruiting
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Nov 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in asthma comparing Magnesium sulfate, Salbutamol and Aminophylline (3 arms). Primary endpoints: Asthma Severity Score at 1 and 2 hours and Asthma Severity Score over time. Started Nov 2025; status: recruiting.
02
Drugs
magnesium sulfatesalbutamolaminophylline
03
Conditions
asthma
Beyond the preview
Go deeper on ISRCTN26012511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26012511.